Observational studyBMC psychiatry2026
Defining a minimal clinically important difference for the Vanderbilt ADHD Parent Rating Scale in children with Attention-Deficit/Hyperactivity Disorder.
Observational study in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAttention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental condition in children and adolescents that poses substantial challenges to health, functioning, and well-being. This study aimed to estimate the minimal clinically important difference (MCID) for the Chinese version of the Vanderbilt ADHD Parent Rating Scale (VAFPRS) and its key score domains using anchor-based and distribution-based methods.
methodsIn this multicenter prospective observational study, 99 children aged 4-17 years who were diagnosed with ADHD were recruited from four tertiary hospitals in China. Caregivers completed the VAFPRS at baseline and follow-up and the Clinical Global Impression-Improvement (CGI-I) scale at follow-up. MCID values were estimated using the anchor-based median change method, the receiver operating characteristic (ROC) curve method, and the distribution-based 0.5 standard deviation (SD) method.
resultsA total of 81 patients completed the follow-up assessment. CGI-I scores were significantly correlated with changes in the total VAFPRS score, core symptoms, inattention, and hyperactivity/impulsivity (r = 0.38-0.43, all p < 0.01). The corresponding anchor-based median MCID estimates were - 8, -5, - 2, and - 3, respectively. ROC curve analysis yielded lower thresholds for these domains (- 3.5, - 2.5, - 1.5, and - 2.5), with acceptable discrimination (AUC ≥ 0.70) for identifying improvement.
conclusionThis study estimated MCID values for the Chinese VAFPRS in children and adolescents with ADHD. Anchor-based median estimates derived from the minimally improved CGI-I group were - 8 for the total score, - 5 for core symptoms, - 2 for inattention, and - 3 for hyperactivity/impulsivity. ROC-derived thresholds were lower and may provide complementary classification cutoffs for identifying improvement status. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.